1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Weber, T.
Schaffhausen, B.
Liu, Y.
Guenther, U.L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C9 H12 N O6 P
261.168
n
O-PHOSPHOTYROSINE
PHOSPHONOTYROSINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
39
15860
15869
10.1021/bi001474d
11123912
NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site.
2000
10.2210/pdb1fu5/pdb
pdb_00001fu5
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
12870.384
PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY ALPHA SUBUNIT
RESIDUES 321 TO 431 OF P85, N-SH2 (SRC HOMOLOGY 2) DOMAIN
1
man
polymer
2063.089
DOUBLY PHOSPHORYLATED MIDDLE T ANTIGEN
RESIDUES 312 TO 326 OF MT ANTIGEN, Y315 AND Y322 PHOSPHORYLATED
1
syn
polymer
PI3-KINASE P85-ALPHA SUBUNIT, PTDINS-3-KINASE P85-ALPHA, PI3K
MT PEPTIDE
no
no
GMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKSIKIFHRDGKYGFSDPLTFNS
VVELINHYRNESLAQYNPKLDVKLLYPVSKY
GMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKSIKIFHRDGKYGFSDPLTFNS
VVELINHYRNESLAQYNPKLDVKLLYPVSKY
A
polypeptide(L)
no
yes
EEE(PTR)MPMEDL(PTR)LDIL
EEEYMPMEDLYLDIL
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Norway rat
Rattus
Escherichia
sample
10116
Rattus norvegicus
562
Escherichia coli
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2001-02-21
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_conn.pdbx_leaving_atom_flag
_struct_ref_seq_dif.details
1FU6 is NMR STRUCTURE OF THE N-SH2 DOMAIN OF THE P85 SUBUNIT OF PI3-KINASE
RCSB
Y
RCSB
2000-09-14
REL
MT peptide was synthesized by the Tufts Protein Chemistry Facility
sample
NOESY assignments were obtained by a semi-automatic procedure employing a program from Pristovsek [Pristovsek, P. & Kidric, J. (1997) Biopol. 42, 671-679)]. Initial calculations included only intramolecular constraints. The observed NOEs derived from 13C{F1}-filtered 2D-NOESY spectra were incorporated into the structure calculation when the protein fold was already correct.
structures with favorable non-bond energy
110
1
2D NOESY
3D_13C-separated_NOESY
3D_15N-separated_NOESY
13C{F1}-filtered 2D-NOESY
0.1mM
6.8
1
bar
305
K
The structure with the lowest energy is presented
The structures were energy minimized with MSI DISCOVER.
1
lowest energy
0.15mM N-SH2 15N, 13C; MT peptide; 0.1mM KCl; 95% H2O, 5% D2O
100% H2O
Ulrich Guenther, Christian Ludwig and Heinz Rueterjans
processing
NMRLAB
M. Kjaer
data analysis
Pronto
P. Pristovsek
data analysis
nmr2st
P. Guentert
structure solution
DYANA
MSI
refinement
Discover
500
Bruker
DMX
600
Bruker
DMX
GLY
1
n
1
GLY
1
A
MET
2
n
2
MET
2
A
ASN
3
n
3
ASN
3
A
ASN
4
n
4
ASN
4
A
ASN
5
n
5
ASN
5
A
MET
6
n
6
MET
6
A
SER
7
n
7
SER
7
A
LEU
8
n
8
LEU
8
A
GLN
9
n
9
GLN
9
A
ASP
10
n
10
ASP
10
A
ALA
11
n
11
ALA
11
A
GLU
12
n
12
GLU
12
A
TRP
13
n
13
TRP
13
A
TYR
14
n
14
TYR
14
A
TRP
15
n
15
TRP
15
A
GLY
16
n
16
GLY
16
A
ASP
17
n
17
ASP
17
A
ILE
18
n
18
ILE
18
A
SER
19
n
19
SER
19
A
ARG
20
n
20
ARG
20
A
GLU
21
n
21
GLU
21
A
GLU
22
n
22
GLU
22
A
VAL
23
n
23
VAL
23
A
ASN
24
n
24
ASN
24
A
GLU
25
n
25
GLU
25
A
LYS
26
n
26
LYS
26
A
LEU
27
n
27
LEU
27
A
ARG
28
n
28
ARG
28
A
ASP
29
n
29
ASP
29
A
THR
30
n
30
THR
30
A
ALA
31
n
31
ALA
31
A
ASP
32
n
32
ASP
32
A
GLY
33
n
33
GLY
33
A
THR
34
n
34
THR
34
A
PHE
35
n
35
PHE
35
A
LEU
36
n
36
LEU
36
A
VAL
37
n
37
VAL
37
A
ARG
38
n
38
ARG
38
A
ASP
39
n
39
ASP
39
A
ALA
40
n
40
ALA
40
A
SER
41
n
41
SER
41
A
THR
42
n
42
THR
42
A
LYS
43
n
43
LYS
43
A
MET
44
n
44
MET
44
A
HIS
45
n
45
HIS
45
A
GLY
46
n
46
GLY
46
A
ASP
47
n
47
ASP
47
A
TYR
48
n
48
TYR
48
A
THR
49
n
49
THR
49
A
LEU
50
n
50
LEU
50
A
THR
51
n
51
THR
51
A
LEU
52
n
52
LEU
52
A
ARG
53
n
53
ARG
53
A
LYS
54
n
54
LYS
54
A
GLY
55
n
55
GLY
55
A
GLY
56
n
56
GLY
56
A
ASN
57
n
57
ASN
57
A
ASN
58
n
58
ASN
58
A
LYS
59
n
59
LYS
59
A
SER
60
n
60
SER
60
A
ILE
61
n
61
ILE
61
A
LYS
62
n
62
LYS
62
A
ILE
63
n
63
ILE
63
A
PHE
64
n
64
PHE
64
A
HIS
65
n
65
HIS
65
A
ARG
66
n
66
ARG
66
A
ASP
67
n
67
ASP
67
A
GLY
68
n
68
GLY
68
A
LYS
69
n
69
LYS
69
A
TYR
70
n
70
TYR
70
A
GLY
71
n
71
GLY
71
A
PHE
72
n
72
PHE
72
A
SER
73
n
73
SER
73
A
ASP
74
n
74
ASP
74
A
PRO
75
n
75
PRO
75
A
LEU
76
n
76
LEU
76
A
THR
77
n
77
THR
77
A
PHE
78
n
78
PHE
78
A
ASN
79
n
79
ASN
79
A
SER
80
n
80
SER
80
A
VAL
81
n
81
VAL
81
A
VAL
82
n
82
VAL
82
A
GLU
83
n
83
GLU
83
A
LEU
84
n
84
LEU
84
A
ILE
85
n
85
ILE
85
A
ASN
86
n
86
ASN
86
A
HIS
87
n
87
HIS
87
A
TYR
88
n
88
TYR
88
A
ARG
89
n
89
ARG
89
A
ASN
90
n
90
ASN
90
A
GLU
91
n
91
GLU
91
A
SER
92
n
92
SER
92
A
LEU
93
n
93
LEU
93
A
ALA
94
n
94
ALA
94
A
GLN
95
n
95
GLN
95
A
TYR
96
n
96
TYR
96
A
ASN
97
n
97
ASN
97
A
PRO
98
n
98
PRO
98
A
LYS
99
n
99
LYS
99
A
LEU
100
n
100
LEU
100
A
ASP
101
n
101
ASP
101
A
VAL
102
n
102
VAL
102
A
LYS
103
n
103
LYS
103
A
LEU
104
n
104
LEU
104
A
LEU
105
n
105
LEU
105
A
TYR
106
n
106
TYR
106
A
PRO
107
n
107
PRO
107
A
VAL
108
n
108
VAL
108
A
SER
109
n
109
SER
109
A
LYS
110
n
110
LYS
110
A
TYR
111
n
111
TYR
111
A
GLU
1
n
1
GLU
1
B
GLU
2
n
2
GLU
2
B
GLU
3
n
3
GLU
3
B
PTR
4
n
4
PTR
4
B
MET
5
n
5
MET
5
B
PRO
6
n
6
PRO
6
B
MET
7
n
7
MET
7
B
GLU
8
n
8
GLU
8
B
ASP
9
n
9
ASP
9
B
LEU
10
n
10
LEU
10
B
PTR
11
n
11
PTR
11
B
LEU
12
n
12
LEU
12
B
ASP
13
n
13
ASP
13
B
ILE
14
n
14
ILE
14
B
LEU
15
n
15
LEU
15
B
author_defined_assembly
2
dimeric
B
PTR
4
O-PHOSPHOTYROSINE
B
PTR
4
TYR
B
PTR
11
O-PHOSPHOTYROSINE
B
PTR
11
TYR
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
B
HD22
HXT
LEU
LEU
12
15
1.06
1
A
A
HZ1
HZ3
LYS
LYS
26
110
1.24
1
A
A
HB3
HZ3
ASP
LYS
67
69
1.26
1
A
A
O
H
LEU
THR
36
51
1.55
1
A
A
O
H
LEU
GLN
93
95
1.56
1
A
A
H
O
ASP
ILE
47
63
1.57
1
A
A
O
H
GLU
ASN
21
24
1.58
1
B
B
C
OXT
LEU
LEU
15
15
0.151
0.019
1.229
1.380
N
1
A
ASN
3
58.86
87.69
1
A
MET
6
-179.89
139.89
1
A
SER
7
62.20
154.39
1
A
GLN
9
34.23
40.07
1
A
ASP
10
-159.73
31.83
1
A
GLU
12
65.24
-73.92
1
A
TYR
14
-87.84
34.40
1
A
ASP
17
52.00
108.25
1
A
SER
19
76.53
103.52
1
A
ARG
20
-30.12
-70.27
1
A
ASP
29
175.70
39.58
1
A
THR
30
-55.68
-77.66
1
A
THR
34
-82.27
45.72
1
A
PHE
35
-42.98
163.63
1
A
LEU
36
177.95
155.86
1
A
ARG
38
-137.31
-44.29
1
A
ASP
39
57.01
147.06
1
A
ALA
40
-177.42
-138.79
1
A
THR
42
-54.68
89.14
1
A
HIS
45
-101.53
71.35
1
A
TYR
48
-158.95
28.77
1
A
THR
49
47.82
-176.16
1
A
LEU
50
178.90
145.00
1
A
ASN
58
60.90
119.69
1
A
SER
60
168.91
-47.41
1
A
ILE
61
57.27
141.32
1
A
LYS
62
174.57
143.71
1
A
ARG
66
-138.93
-85.01
1
A
ASP
67
-100.04
61.81
1
A
TYR
70
-53.87
-165.98
1
A
PHE
72
-36.50
-31.83
1
A
ASP
74
61.83
86.70
1
A
THR
77
152.61
44.96
1
A
VAL
81
-90.69
38.51
1
A
ASN
90
151.18
116.95
1
A
GLU
91
154.99
-18.51
1
A
SER
92
89.48
160.90
1
A
ALA
94
-65.37
64.20
1
A
GLN
95
-66.53
-84.37
1
A
ASN
97
-178.70
148.35
1
A
PRO
98
-75.00
48.19
1
A
LEU
100
-125.30
-76.80
1
A
ASP
101
30.35
66.06
1
A
LYS
103
78.26
164.55
1
A
LEU
104
-160.29
27.24
1
A
LYS
110
46.20
93.25
1
B
GLU
3
-77.45
-121.99
1
B
MET
7
169.34
152.39
1
B
GLU
8
174.66
-99.29
1
B
ASP
9
73.44
126.14
1
B
LEU
10
-36.75
137.47
1
B
ASP
13
43.22
-165.34
NMR STRUCTURE OF THE N-SH2 DOMAIN OF THE P85 SUBUNIT OF PI3-KINASE COMPLEXED TO A DOUBLY PHOSPHORYLATED PEPTIDE DERIVED FROM POLYOMAVIRUS MIDDLE T ANTIGEN
1
N
N
2
N
N
A
SER
19
A
SER
19
HELX_P
A
LEU
27
A
LEU
27
1
1
9
A
VAL
82
A
VAL
82
HELX_P
A
TYR
88
A
TYR
88
1
2
7
covale
1.325
both
B
GLU
3
B
C
GLU
3
1_555
B
PTR
4
B
N
PTR
4
1_555
covale
1.324
both
B
PTR
4
B
C
PTR
4
1_555
B
MET
5
B
N
MET
5
1_555
covale
1.325
both
B
LEU
10
B
C
LEU
10
1_555
B
PTR
11
B
N
PTR
11
1_555
covale
1.325
both
B
PTR
11
B
C
PTR
11
1_555
B
LEU
12
B
N
LEU
12
1_555
PEPTIDE BINDING PROTEIN
protein-peptide complex, PEPTIDE BINDING PROTEIN
P85A_RAT
UNP
1
321
Q63787
GMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFNS
VVELINHYRNESLAQYNPKLDVKLLYPVSKY
TAMI_POVM3
UNP
2
331
P03076
EEEYMPMEDLYLDIL
321
431
1FU5
1
111
Q63787
A
1
1
111
331
345
1FU5
1
15
P03076
B
2
1
15
1
LEU
conflict
SER
60
1FU5
A
Q63787
UNP
380
60
2
TYR
modified residue
PTR
4
1FU5
B
P03076
UNP
334
4
2
TYR
modified residue
PTR
11
1FU5
B
P03076
UNP
341
11
1
P 1